TORONTO, April 12 /CNW/ - ARIUS Research Inc., ("ARIUS" or the "Company")
(TSX: ARI), a biotechnology company discovering and developing the next wave
of antibody therapeutics, today announced its financial and operational
results for the first quarter, ended February 28, 2007.
